H syndrome is a rare autosomal recessive disorder that occurs because of mutations in the SLC29A3 gene, encoding the human equilibrative nucleoside transporter, which is a protein located in endosomes, lysosomes, and mitochondria.1, 2, 3, 4, 5 It was first named by Molho-Pessach et al in 2008.1 To date, fewer than 120 cases of this rare disease have been reported worldwide.5 It is characterized by the presence of hyperpigmented indurated patches with overlying hypertrichosis symmetrically involving the inner aspects of the thighs, which may extend to the posterior aspects of the lower limbs, abdomen, and back, while sparing the knees and buttocks. Other important features of H syndrome include sensorineural hearing loss, hyperglycemia/insulin-dependent diabetes mellitus, heart anomalies, hypogonadism, low height (short stature), and hepatosplenomegaly.1, 2, 3, 4, 5, 6 Currently, many investigators consider H syndrome as a novel form of histiocytosis.4,7 In this case series, 3 cases are reported with findings consistent with H syndrome, in addition to new findings that have not been reported in the literature. All 3 of our patients have low bone mineral density associated with musculoskeletal pain, they also have hypovitaminosis D with secondary hyperparathyroidism, and they responded well to vitamin D supplements.